Related Experiment Video

Updated: Aug 21, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

[Dysaggregants effect of platelet aggregation in patients with non-ST segment elevation acute coronary syndrome]

T M Poponina, N A Kapilevich, I V Kisteneva

    Terapevticheskii Arkhiv
    |October 9, 2004
    PubMed

    Insights

    Combination therapy with clopidogrel and cardiomagnil demonstrated the highest antiplatelet effect in acute coronary syndrome without ST segment elevation (ACS without STSE) patients. Monitoring platelet function allows for personalized ACS treatment strategies.

    Area of Science:

    • Cardiology
    • Pharmacology
    • Internal Medicine

    Background:

    • Acute coronary syndrome without ST segment elevation (ACS without STSE) requires effective antiplatelet therapy.
    • Platelet aggregation plays a critical role in the pathophysiology of ACS without STSE.

    Purpose of the Study:

    • To evaluate the efficacy of different platelet dysaggregation drugs in patients with ACS without STSE.
    • To compare the antiplatelet effects of aspirin, cardiomagnil, and clopidogrel, both individually and in combination.

    Main Methods:

    • 78 patients with ACS without STSE were randomized into five groups.
    • Groups received no dysaggregants, aspirin, cardiomagnil, clopidogrel, or a combination of clopidogrel and cardiomagnil.
    • All patients received fraxiparin, and platelet function was monitored.

    Main Results:

    • Patients not receiving dysaggregants showed platelet hyperaggregation.
    • Aspirin, cardiomagnil, and clopidogrel reduced platelet aggregation, with some aspirin resistance noted.
    • The combination of clopidogrel and cardiomagnil yielded the most significant antiaggregation effect.

    Conclusions:

    • Individualized antiplatelet therapy selection is crucial for ACS without STSE patients.
    • Monitoring platelet function enables the optimization of treatment strategies.
    • Combination therapy may offer superior outcomes in specific patient populations.
    Abstract

    More Related Videos

    Analyzing Platelet Subpopulations by Multi-color Flow Cytometry08:04

    Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

    Published on: June 10, 2025

    Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation09:13

    Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

    Published on: April 6, 2017

    Related Concept Videos

    Formation of the Platelet Plug01:22

    Formation of the Platelet Plug

    The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
    As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
    Acute Coronary Syndrome I: Introduction01:30

    Acute Coronary Syndrome I: Introduction

    Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
    Clot Retraction and Fibrinolysis01:16

    Clot Retraction and Fibrinolysis

    After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
    Acute Coronary Syndrome III: Diagnostic Studies01:30

    Acute Coronary Syndrome III: Diagnostic Studies

    Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
    Coronary Artery Disease II: Pathophysiology01:26

    Coronary Artery Disease II: Pathophysiology

    Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...